piracetam has been researched along with bradykinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annunziato, L; Cataldi, M; di Renzo, G; Lariccia, V; Secondo, A | 1 |
| DeLorenzo, RJ; Deshpande, LS; Nagarkatti, N | 1 |
2 other study(ies) available for piracetam and bradykinin
| Article | Year |
|---|---|
The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]I increase induced by ATP and bradykinin in PC12 cells.
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Bradykinin; Calcium; Dose-Response Relationship, Drug; Inositol 1,4,5-Trisphosphate; Levetiracetam; PC12 Cells; Piracetam; Rats | 2005 |
Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.
Topics: Animals; Animals, Newborn; Bradykinin; Caffeine; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Neurons; Nootropic Agents; Phosphodiesterase Inhibitors; Piracetam; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel | 2008 |